Introduction: Parenteral nutrition (PN) impairs mucosal immunity and increases the risk of infection in part via lower IgA levels at mucosal surfaces. Transport of immunoglobulin A (IgA) across the mucosa to the gut lumen depends on the epithelial transport protein, polymeric immunoglobulin receptor (pIgR), which is reduced during PN. In vitro, studies demonstrate that IL-4 up-regulates pIgR production via Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling. Because IL-4 stimulates IgA and is reduced during PN, we hypothesized that the suppressed pIgR is a result of decreased JAK-1 and STAT-6 phosphorylation. Because IL-4 is mediated by IL-25, we also hypothesized that PN + IL-25 would restore luminal IgA by increasing phosphorylated JAK-1 and STAT-6, resulting in increased tissue pIgR and luminal IgA. Method: Experiment 1: 2 days after intravenous cannulation, male Institute of Cancer Research mice were randomized to chow (n = 11) or PN (n = 9). Experiment 2: 2 days after intravenous cannulation, male Institute of Cancer Research mice were randomized to chow (n = 12), PN (n = 10), or PN + 0.7 μg of exogenous IL-25 (n = 11) per day. After 5 days, distal ileum tissue was collected, homogenized, and protein extracted for JAK-STAT expression levels using a phospho-specific antibody microarray. Tissue was homogenized to measure pIgR expression via Western blot or fixed in 4% paraformaldehyde to measure pIgR expression via immunohistochemistry. Small intestinal wash fluid was collected and IgA was quantified using enzyme-linked immunosorbent assay. Results: Experiment 1: PN significantly reduced phosphorylated JAK-1 and STAT-6 compared with chow. PN also decreased the tissue levels of the Th2 cytokines, IL-4 and IL-13, as well as pIgR, and luminal IgA compared with chow. Experiment 2: Exogenous administration of PN + IL-25 increased the phosphorylated JAK-1 and STAT-6 compared with PN alone. IL-25 completely restored expression of IL-13 to chow levels. IL-4, pIgR, IgA, and phosphorylated JAK-1 were significantly increased with IL-25 treatment compared with PN but failed to reach levels measured in chow. STAT-6 was significantly increased with IL-25 treatment compared with chow and PN. Conclusions: PN significantly decreases the JAK-STAT pathway by reducing levels of phosphorylated STAT-6 and JAK-1. Consistent with our previous work, sIgA, pIgR, and IL-4 decreased with PN, whereas the addition of IL-25 to PN reversed these decreases and demonstrated the role of the JAK-STAT pathway in vivo during PN.
P arenteral nutrition (PN) is associated with an increased risk of infectious complications in critically ill patients compared with enteral feeding. [1] [2] [3] [4] Experimentally, PN alters established mucosal immune defenses by decreasing the total number of lymphocytes throughout the gut-associated lymphoid tissue including Peyer Patches, the intraepithelial space, and the lamina propria. 5 PN also reduces levels of 2 IgA-stimulating Th2 cytokines, IL-4 and IL-10, in the small intestine 6 and decreases the primary adaptive immune molecule, immunoglobulin A (IgA), which is transported by epithelial cells from the lamina propria onto the mucosal surfaces. 5, 7, 8 The reduction of IgA levels after PN is, in part, through reduced production of the primary transport protein, polymeric immunoglobulin receptor (pIgR). 9, 10 These changes in the mucosal immune system with PN are consistent with the increased risk of infection in hospitalized patients.
The Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathway is one of the pleiotropic cascades employed to transduce many cell-signaling events and is activated by hormones, growth factors, and cytokines. [11] [12] [13] [14] [15] [16] JAK/STAT provides the principal intracellular signaling mechanism required for a wide array of cytokines including IL-2, IL-3, IL-4, IL-6, IL-7, IL-9, IL-11, IL-13, IL-15, and IFN-γ . [16] [17] [18] Among other functions, JAK/STAT proteins influence cell development and immune stimulation. 19 Specifically, the Th2 cytokines IL-4 and IL-13 stimulate differentiation and maturation of B cells. 20, 21 Binding of IL-4 and IL-13 to an IL-4 receptor initiates activation of JAK proteins through phosphorylation. Activated JAK proteins then phosphorylate a tyrosine residue on STAT-6, which otherwise remains latent in the cytoplasm. Uniquely, IL-4 and IL-13 induce tyrosine phosphorylation and activation of STAT-6. In vitro work demonstrates that the activated STAT-6 forms dimmers, translocates to the nucleus where it binds specific deoxyribonucleic acid elements, and activates transcription of several products, including pIgR. [22] [23] [24] [25] [26] [27] Another Th2 cytokine, IL-25, provides powerful stimulatory effects to promote Th2 immunity by increasing expression of IL-4, IL-9, and IL-13. 28, 29 Exogenous administration of IL-25 elicits a strong Th2 response in vivo and in vitro.
Because the lack of enteral feeding during PN reduces adaptive immunity by decreasing IgA, pIgR, and Th2 cytokines, we hypothesized that a lack of enteral stimulation during PN would decrease levels of phosphorylated JAK-1 and phosphorylated STAT-6 and impair adaptive immunity. We further hypothesized that administration of IL-25, a known potent stimulator of Th2 responses, during PN feeding would reverse these changes and increase levels of IgA-, pIgR-, and other Th-2-type cytokines through increased levels of phosphorylated JAK-1 and phosphorylated STAT-6.
Male Institute of Cancer Research mice, with ages 6 to 8 weeks, were randomized to chow (chow, n = 9) or PN (n = 11). Animals were anesthetized by intramuscular injection, weighed, and underwent placement of a silicon rubber catheter (0.012-inch ID/0.025-inch OD; Helix Medical, Inc, Carpinteria, CA) in the vena cava through the right external jugular vein. The catheter was tunneled subcutaneously and exited at the midpoint of the tail. The animals were housed individually in metabolic cages with wire floors to prevent coprophagia and bedding ingestion and partially immobilized by a tail restraint to protect the catheter during infusion. This technique has proven to be an acceptable method of nutritional support and does not produce physical or biochemical evidence of stress. 30 The catheterized mice were connected to infusion pumps and received saline (0.9%) at 4 mL per day and ad libitum chow and water during 48 hours of recovery. After 48 hours, chow mice continued to receive 0.9% saline at 4 mL per day and ad libitum chow and water. PN animals received PN solution at rates 4 mL per day (day 1), 7 mL per day (day 2) and 10 mL per day (day 3-5), because a graded infusion period was demonstrated to be necessary for the mice to adapt to the glucose and fluid loads. The PN solution contained 6.0% amino acids, 35.6% dextrose, electrolytes, and multivitamins, containing 1440 kcal/L and a nonprotein calories:nitrogen ratio of 128:1. These values were calculated to meet the nutrient requirements of mice weighting 25 to 30 g. 31 After 5 days of feeding (7 days postcatheterization), mice were anesthetized by an intraperitoneal injection of ketamine (100 mg/kg) and acepromazine (10 mg/kg) and exsanguinated via left axillary artery transection. The small intestine was removed and the lumen rinsed with 20 mL Hanks Balanced Saline Solution (Bio Whittaker, Walkersville, MD). The luminal rinse was centrifuged at 2000× g for 10 minutes, supernatant aliquots were frozen at −80 • C, and IgA was quantified by enzyme-linked immunosorbent assay. Tissue samples were taken by removing a 3-cm segment of ileum, excluding Peyer patches. These samples were frozen in liquid nitrogen and stored at −80 • C until processing.
Experiment 2: Exogenous IL-25 and PN Effects on Th2 Cytokines, IgA, and pIgR
Male Institute of Cancer Research mice, with ages 6 to 8 weeks, were cannulated as in experiment 1 and randomized to chow (chow, n = 12), PN (n = 12), or PN with exogenous intravenous IL-25 [0.7 μg per mouse per day (R&D Systems)] for 5 days (IL-25, n = 12). Chow and PN animals also received a saline vehicle control to the IL-25 treatment vehicle. Tissues were harvested as previously mentioned. Ileum tissue was collected and fixed in 4% paraformaldehyde overnight at 4 • C for analysis of pIgR expression using immunofluorescence.
JAK-STAT Profiling by the JAK-STAT Antibody Microarray
The Phospho Explorer antibody microarray (Full Moon Biosystems, Inc, Sunnyvale, CA) contains 42 antibodies. Each of the antibodies has 6 replicates that are printed on a coated glass microscope slide, along with multiple positive and negative controls. The antibody array experiment was performed according to estab-lished protocol. 32 In brief, Ileum tissue lysates were biotinylated with Antibody Array Assay Kit. The antibody microarray slides were first blocked in a blocking solution for 30 minutes at room temperature, rinsed with Milli-Q grade water for 3 to 5 minutes, and dried with compressed nitrogen. The slides were then incubated with the biotinlabeled cell lysates (approximately 80 μg protein) in coupling solution at room temperature for 2 hours. The array slides were washed 5 times with 1X Wash Solution and rinsed extensively with Milli-Q grade water before detection of bound biotinylated proteins using Cy3-conjugated streptavidin. The slides were scanned on a GenePix 4000 scanner, and the images were analyzed with GenePix Pro 6.0 (Molecular Devices, Sunnyvale, CA). The fluorescence signal (I) of each antibody was obtained from the fluorescence intensity of this antibody spot after subtraction of the blank signal (spot in the absence of antibody), and we used the signal of the phosphorylated protein to nonphosphorylated protein.
Analysis of Tissue IL-4 and IL-13
Small intestine segments were homogenized in RIPA lysis buffer (Upstate, Lake Placid, NY) containing 1% protease inhibitor cocktail (P8340 Sigma-Aldrich, St Louis, MO). The homogenates were incubated for 30 minutes on ice before centrifugation at 16,000× g for 10 minutes at 4 • C. All supernatants were stored at −20 • C until analyzed. Protein concentrations for each homogenate were determined by the Bradford dye binding method using bovine serum albumin as is standard.
Concentrations of IL-4 and IL-13 were measured in the small intestinal tissue homogenate using a solid phase sandwich enzymelinked immunosorbent assay (BD Biosciences, San Diego, CA). Briefly, 96-well plates (Costar, 9018) were coated in 0.1 M sodium carbonate coating buffer (pH 9.5) with 100 μL per well containing antimouse IL-4 or IL-13 in a 1:250 dilution. After an overnight incubation at 4 • C, the plates were washed 3 times with wash buffer and blocked with 200 μL of phosphate-buffered saline containing 10% fetal bovine serum for 1 hour at room temperature. One hundred microliters of tissue homogenate or cytokine standard (BD Biosciences) were added to respective wells. After incubation for 2 hours at room temperature, plates were washed 5 times. One hundred microliters of a 1:250 dilution of secondary antibody were added and incubated for 1 hour at room temperature. Plates were washed 5 times before streptavidin-horseradish peroxidase conjugate was added, and the mixture was incubated for 30 minutes at room temperature. Reactions were stopped by adding 50 μL of 2N H 2 SO 4 , and the absorbance was read at 450 nm in a Vmax Kinetic Microplate Reader. The mass amounts were determined by plotting sample absorbance values on a 4-parameter logistic fit standard curve, as calculated with SOFTmax PRO software (Molecular Devices).
Experiment 2: Immunofluorescence
Because IL-25 increases intestinal smooth muscle protein, a known effect of this cytokine, analysis of pIgR based on protein standardization was not appropriate. For this reason, immunofluorescence, instead of Western blot, was used in experiment 2 to quantify mucosal pIgR. Immunofluorescence of pIgR was performed by fixed intestinal segments in 4% formalin overnight, processing (Tissue-Tek VIP), and embedded in paraffin. Sections were cut (5 microns) and deparaffinized with heat and xylene. Samples were rehydrated and antigen retrieval was performed with HIER (10 mM Citrate buffer, pH 6.0) in a DeCloaking Chamber for 2 minutes. Slides were rinsed and blocked with 10% bovine serum albumin (BSA) in phosphatebuffered saline for 1 hour at room temperature. Sections were incubated with pIgR primary antibody (1:100, Goat antimouse polyclonal antibody, AF2800, R&D Systems, Minneapolis, MN) in 1% BSA with phosphate-buffered saline for 1 hour at room temperature. Sections were rinsed and incubated with secondary antibody (1:50, Alexa Fluor 594, Donkey antigoat, Invitrogen, Grand Island, NY) in 1% BSA with phosphate-buffered saline for 30 minutes at room temperature. Slides were rinsed and 4',6-diamidino-2-phenylindole (P36935, Invitrogen) was applied to slides to image nuclei before coverslipping. Slides were imaged on a Nikon e600 microscope using an Olympus DP70 camera. Total pIgR expression from 12 to 15 villi per animal was measured over the total epithelial area using NIH ImageJ software.
IgA Antibody Quantitative Analysis
IgA concentration from the small intestine (SI) luminal fluid was measured using a sandwich enzyme-linked immunosorbent assay. Methods were identical to those previously published. 35 Small intestinal luminal IgA concentrations were calculated by plotting absorbance values for an IgA standard curve, which was calculated using a 4-parameter logistic fit with SOFTmax PRO software (Molecular device).
Statistical Analysis
The data are expressed as means ± standard error of the mean. Statistical significance was determined using analysis of variance with Fisher protected least significant difference post hoc test. Differences were considered to be statistically significant at P < 0.05. All statistical calculations were performed with StatView (Abacus Concepts, Berkeley, CA).
RESULTS

Experiment 1: PN Effects on JAK-STAT Signaling
Microarray Analysis of Phosphorylated JAK-1 and STAT-6
Compared with chow, PN feeding decreased the ratios of phosphorylated to nonphosphorylated STAT-6 (PN: 1.06 ± 0.02 vs chow: 1.16 ± 0.02, P = 0.004) and phosphorylated to nonphosphorylated JAK-1 (PN: 1.23 ± 0.04 vs chow: 1.86 ± 0.24, P = 0.04) in intestinal tissue (Fig. 1 ).
Tissue Levels of IL-4, IL-13, and pIgR
PN significantly reduced tissue levels of both IL-4 (PN: 23.4 ± 1.6 pg/mg vs chow: 34.5 ± 2.7 pg/mg, P = 0.002) and IL-13 (PN: 4.4 ± 0.6 pg/mg vs chow: 8.7 ± 1.5 pg/mg, P = 0.02) (Fig. 2 ) compared with chow feeding. Tissue levels of pIgR (μg pIgR/40 μg tissue protein) measured by Western blot were significantly depressed in PN mice compared with chow controls (PN: 0.41 ± .08 vs 0.75 ± 0.06, P = 0.003) ( Fig. 3 ).
Luminal Levels of IgA in Small Intestinal Wash Fluid
Consistent with our previous reports, PN significantly reduced intestinal fluid IgA compared with chow (188.1 ± 23.4 vs 387.4 ± 37.9 ng/mL, P < 0.0001) ( Fig. 4 ).
Experiment 2: IL-25 Stimulation of PN Microarray Analysis of Phosphorylated STAT-6 and JAK-1
Consistent with the first experiment, PN significantly decreased the ratios of phosphorylated to nonphosphorylated STAT-6 (PN: 0.51 ± 0.02 vs chow: 0.65 ± 0.04, P = 0.04) ( 
Tissue IL-4 and IL-13 Levels
Consistent with Experiment 1, PN significantly decreased the tissue levels of IL-4 compared with chow-fed mice (PN: 22.1 ± 0.9 pg/mg protein vs chow: 34.5 ± 2.7 pg/mg protein, P = 0.0003) (Fig. 6A ). The addition of IL-25 to PN significantly increased tissue IL-4 compared with PN alone (PN + IL-25: 28.4 ± 1.8 pg/mg protein vs PN: 22.1 ± 0.9 pg/mg protein, P = 0.03), the IL-4 levels remained lower than chow levels (PN+ IL-25: 28.4 ± 1.8 pg/mg protein vs chow: 34.5 ± 2.7 pg/mg protein, P < 0.05). PN significantly reduced tissue levels of IL-13 (pg/mg) compared with chow levels (PN: 8.1 ± 1.0 vs chow: 15.3 ± 1.8, P = 0.002) (Fig. 6B ). The addition of IL-25 to PN significantly increased IL-13 tissue levels compared with PN alone (PN + IL-25: 13.9 ± 1.6 vs PN: 8.1 ± 1.0, P = 0.005) and the IL-13 levels were similar to chow levels (PN + IL-25: 15.3 ± 1.8 vs chow: 13.9 ± 1.6, P = 0.5). 
Immunohistochemical Analysis of pIgR Expression in Ileum Tissue
PN significantly decreased the expression of pIgR (pIgR/total mucosa area in %) as a percentage of total mucosal area in ileal tissue compared with chow alone (PN: 0.34 ± 0.04 vs chow: 0.61 ± 0.02, P = 0.0002). The addition of IL-25 to PN significantly increased expression of pIgR in ileal tissue compared with PN alone (PN + IL-25: 0.51 ± 0.01 vs PN: 0.34 ± 0.04, P = 0.003), but pIgR after IL-25 treatment mice were still significantly depressed compared with chow mice (PN + IL-25: 0.51 ± 0.01 vs chow: 0.61 ± 0.02, P = 0.04) ( Fig. 7) . 
IgA Concentration in Small Intestinal Wash Fluid
DISCUSSION
PN provides nutrition to patients unable to be fed enterally. Its use, however, is associated with clinical increases in infectious complications in critically ill patients. Our previous work has defined a cogent explanation for this clinical observation: an impaired adaptive mucosal immune function during PN. This impairment is multifactorial. Compared with enteral feeding, PN decreases total gut-associated lymphoid tissue T and B lymphocytes,, 5 Th2 cytokines, 6 IgA at mucosal surfaces, 5, 8 and the IgA transport protein, pIgR. 9, 36 This study expands on our previous observations by examining the involvement of the JAK/STAT pathways.
The JAK/STAT pathways regulate the IgA transport protein, pIgR. STAT6 transcription stimulates production of intestinal pIgR. STAT-6 transcription is generated by the Th2 cytokines, IL-4, and IL-13. These cytokines utilize a common receptor and signal solely through phosphorylation of JAK-1 and STAT-6. Because our prior works showed intestinal IL-4 drops during PN, this work examined changes in phosphorylation of tissue JAK-1 and STAT-6 proteins during PN feeding and confirmed a reduction in phosphorylation. We showed PN led to reductions in phosphorylated JAK-1 and STAT-6 compared with enteral feeding. Consistent with our previous work, PN resulted in lower levels of tissue IL-4, pIgR, and luminal IgA. We also observed, for the first time, that PN significantly reduced the Th2 cytokine, IL-13, in the intestinal tissue. These data supported our working hypothesis that PN diminishes established adaptive immunity by decreasing levels of phosphorylated JAK-1 and STAT-6, which are necessary mediators of pIgR transcription. However, these observations did not establish a direct causal relationship between the Th2 cytokines and pIgR-mediated IgA protection. Our second experiment confirmed the causal relationship between the JAK/STAT pathway and pIgR production by stimulating the STAT-6 pathway with exogenous IL-25. IL-25 is a powerful Th2 cytokine that promotes production of IL-4 and IL-13 both in vitro and in vivo. 28, 29 with PN alone. These results established a direct relationship between the JAK-STAT signaling pathway with the Th2 cytokines IL-4 and IL-13 and the effector functions of adaptive immunity, that is, IgA levels in the intestinal fluid. Interestingly, IL-25 significantly improved JAK-1, IL-4, IgA, and pIgR compared with PN alone, but not all of these parameters were restored to chow levels. This partial restoration indicates involvement of other stimuli and signaling pathways in the production of IgA and the epithelial transport protein, pIgR. For example, our prior work showed that IL-10, another Th-2 cytokine important in IgA production, decreases with PN; there is no evidence that IL-25 stimulates release of this cytokine, which could have blunted the response in non-chow-fed mice. IL-25 does exert its effects on other pathways separate from the Th2 cytokines. For example, exogenous administration of IL-25 causes proliferation of smooth muscle actin, 37, 38 an effect demonstrated in our microarray analysis. This mandated the use of different methods for quantification of pIgR in the 2 experiments, as detailed in the methodology. The IL-25-stimulated smooth muscle hypertrophy elevated the house keeping proteins normally used for Western blot analysis. Therefore, to appropriately quantify pIgR in experiment 2, we used immunofluorescent imaging of the mucosa and measured pIgR expression levels directly. Thus, our partial restoration of adaptive parameters may be a consequence of the actions of IL-25 on other signaling pathways, which were not measured in this work.
There are several additional limitations to this study. First, we used whole intestinal tissue for our analysis and did not examine specific cell types. Thus, we are unable to attribute the effects to a specific cellular compartment such as lamina propria or intraepithelial cell types. Instead, our results represent changes to our measured parameters for the piece of ileum tissue as a whole. Second, we did not examine the IL-25 effects on other mucosal events. For instance, IL-25 also stimulates the Th2 cytokine IL-5, 39, 40 a cytokine that induces eosinophilic responses. In addition, others have shown IL-25 causes increased mucus production and epithelial cell hyperplasia and hypertrophy within the lung and intestinal tissue. 41 The additional pathways stimulated by IL-25 could contribute to the partial restoration of IgA we observed in this work. Although IL-25 contributions to other cell types and tissues were beyond the scope of the current investigation, further experiments exploring the ramifications of exogenous IL-25 administration and the effects on other pathways are currently under investigation.
In summary, this study suggests a mechanism for the PNinduced reduction in the IgA transport protein, pIgR. Consistent with our hypothesis, we showed that PN decreases IL-4 and IL-13, the Th2 cytokines, which normally stimulate phosphorylation levels of JAK-1 and STAT-6 and documented a reduction in the JAK-STAT pathway activation. We established a causal relationship between the IgA transport system and the JAK-STAT pathway by administering IL-25 to PN-fed mice. IL-25 partially restored this transportation system by increasing expression of Th2 cytokines, phosphorylated JAK-1 and phosphorylated STAT-6, IgA, and the transport protein pIgR. This work demonstrates that PN-induced vulnerabilities in adaptive mucosal immunity are at least partly driven by Th2 cytokine production and release.
